Stay updated on Semaglutide Once-weekly vs Placebo add-on to SGLT-2i in T2DM Clinical Trial

Sign up to get notified when there's something new on the Semaglutide Once-weekly vs Placebo add-on to SGLT-2i in T2DM Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Semaglutide Once-weekly vs Placebo add-on to SGLT-2i in T2DM Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page now shows revision v3.5.5, replacing the previous v3.5.4. This reflects a minor platform update that does not affect the study details or other visible content.
    Difference
    0.0%
    Check dated 2026-06-06T14:24:19.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    Added revision tag v3.5.4 and removed v3.5.3, indicating an update to the page's underlying revision/version.
    Difference
    0.0%
    Check dated 2026-05-15T23:54:51.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    The page footer revision was updated from “Revision: v3.5.0” to “Revision: v3.5.3,” reflecting a ClinicalTrials.gov site/version release rather than any change to the study information.
    Difference
    0.0%
    Check dated 2026-04-24T16:40:26.000Z thumbnail image
  6. Check
    82 days ago
    Change Detected
    Summary
    - Added Revision: v3.5.0 and removed Revision: v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-19T19:47:25.000Z thumbnail image
  7. Check
    118 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-12T02:34:28.000Z thumbnail image
  8. Check
    125 days ago
    Change Detected
    Summary
    The only change observed is a revision update on the page from v3.4.0 to v3.4.1, with no alteration to study details, eligibility criteria, outcomes, locations or other user-visible content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-05T00:26:17.000Z thumbnail image

Stay in the know with updates to Semaglutide Once-weekly vs Placebo add-on to SGLT-2i in T2DM Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Semaglutide Once-weekly vs Placebo add-on to SGLT-2i in T2DM Clinical Trial page.